AbbVie 2013 Annual Report Download - page 158

Download and view the complete annual report

Please find page 158 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

Option Awards Stock Awards
Number of Number of Number of
Number of Shares of Shares of Shares of
Unexercised Number of Number of Number of Restricted Restricted Restricted
Shares Option Option Option Number of Stock/ Stock/ Stock/
Remaining Shares Shares Shares Shares of Units Units Units
from Vesting— Vesting— Vesting— Restricted Vesting— Vesting— Vesting—
Original Date Date Date Stock/ Date Date Date
Name Grant Vested 2014 Vested 2015 Vested 2016 Units Vested 2014 Vested 2015 Vested 2016
W. Chase ...... 6,333 6,333—2/18 4,500 (a)
13,066 6,533—2/17 6,533—2/17 7,266 (b)
115,830 38,610—2/14 38,610—2/14 38,610—2/14 56,700 (c)
44,401 (d)
C. Alban ...... 15,267 15,267—2/18 10,833 (a)
32,066 16,033—2/17 16,033—2/17 17,800 (b)
115,830 38,610—2/14 38,610—2/14 38,610—2/14 56,700 (c)
35,521 (d)
T. Richmond . . . . 87,040 29,014—2/14 29,013—2/14 29,013—2/14 10,000 10,000—2/01
1,533 1,533—2/18
3,300 1,650—2/17 1,650—2/17
42,610 (c)
29,600 (d)
(a) These are the shares of restricted stock that remained outstanding and unvested on December 31,
2013, from an award made on February 18, 2011. The award has a 5-year term, with no more than
one-third of the original award vesting in any one year upon AbbVie achieving a minimum return
on equity target, measured at the end of the relevant year. In 2013, AbbVie reached its minimum
return on equity target and these shares vested on February 28, 2014.
(b) These are the shares of restricted stock that remained outstanding and unvested on December 31,
2013, from an award made on February 17, 2012. The award has a 5-year term, with no more than
one-third of the original award vesting in any one year upon AbbVie achieving a minimum return
on equity target, measured at the end of the relevant year. In 2013, AbbVie reached its minimum
return on equity target and one half of the unvested shares vested on February 28, 2014.
(c) These are the shares of restricted stock that remained outstanding and unvested on December 31,
2013, from an award made on February 14, 2013. The award has a 5-year term, with no more than
one-third of the original award vesting in any one year upon AbbVie achieving a minimum return
on equity target, measured at the end of the relevant year. In 2013, AbbVie reached its minimum
return on equity target and one third of the unvested shares vested on February 28, 2014.
(d) These are the shares of restricted stock that remained outstanding and unvested on December 31,
2013, from an award made on December 1, 2012. These shares will vest after January 1, 2016
subject to continued employment with AbbVie through the vesting date and AbbVie achieving a
minimum return on equity target for the period 2013 through 2015.
(4) These are restricted stock units that remained outstanding and unvested on December 31, 2013, from an
award made on February 18, 2011. The award has a 3-year term, with one-third of the original award
vesting on each of the first three anniversaries of the grant date.
(5) These are restricted stock units that remained outstanding and unvested on December 31, 2013, from an
award made on February 17, 2012. The award has a 3-year term, with one-third of the original award
vesting on each of the first three anniversaries of the grant date.
35